These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 7543929)
1. d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites. De Deurwaerdère P; Bonhomme N; Le Moal M; Spampinato U J Neurochem; 1995 Sep; 65(3):1100-8. PubMed ID: 7543929 [TBL] [Abstract][Full Text] [Related]
2. Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors. De Deurwaerdère P; Stinus L; Spampinato U J Neurosci; 1998 Aug; 18(16):6528-38. PubMed ID: 9698340 [TBL] [Abstract][Full Text] [Related]
3. Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites. De Deurwaerdère P; Bonhomme N; Lucas G; Le Moal M; Spampinato U J Neurochem; 1996 Jan; 66(1):210-5. PubMed ID: 8522956 [TBL] [Abstract][Full Text] [Related]
4. Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated. Lucas G; De Deurwaerdère P; Porras G; Spampinato U Neuropharmacology; 2000 Aug; 39(11):1984-95. PubMed ID: 10963742 [TBL] [Abstract][Full Text] [Related]
5. 5-HT3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo. Santiago M; Machado A; Cano J Br J Pharmacol; 1995 Sep; 116(1):1545-50. PubMed ID: 8564217 [TBL] [Abstract][Full Text] [Related]
6. Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat. Bonhomme N; De Deurwaèrdere P; Le Moal M; Spampinato U Neuropharmacology; 1995 Mar; 34(3):269-79. PubMed ID: 7543190 [TBL] [Abstract][Full Text] [Related]
7. In vivo neurochemical evaluation of striatal serotonergic hyperinnervation in rats depleted of dopamine at infancy. Jackson D; Abercrombie ED J Neurochem; 1992 Mar; 58(3):890-7. PubMed ID: 1371152 [TBL] [Abstract][Full Text] [Related]
8. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Nomikos GG; Damsma G; Wenkstern D; Fibiger HC Synapse; 1990; 6(1):106-12. PubMed ID: 1697988 [TBL] [Abstract][Full Text] [Related]
9. Serotonin stimulation of 5-HT4 receptors indirectly enhances in vivo dopamine release in the rat striatum. De Deurwaerdère P; L'hirondel M; Bonhomme N; Lucas G; Cheramy A; Spampinato U J Neurochem; 1997 Jan; 68(1):195-203. PubMed ID: 8978726 [TBL] [Abstract][Full Text] [Related]
10. Influence of serotoninergic drugs on in vivo dopamine extracellular output in rat striatum. Santiago M; Matarredona ER; Machado A; Cano J J Neurosci Res; 1998 Jun; 52(5):591-8. PubMed ID: 9632315 [TBL] [Abstract][Full Text] [Related]
11. Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats. Ferré S; Cortés R; Artigas F J Neurosci; 1994 Aug; 14(8):4839-46. PubMed ID: 7519257 [TBL] [Abstract][Full Text] [Related]
12. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain. Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP J Neurochem; 1990 Jun; 54(6):1834-43. PubMed ID: 2338544 [TBL] [Abstract][Full Text] [Related]
13. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. Robertson GS; Damsma G; Fibiger HC J Neurosci; 1991 Jul; 11(7):2209-16. PubMed ID: 1712381 [TBL] [Abstract][Full Text] [Related]
14. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats. Gołembiowska K; Dziubina A Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831 [TBL] [Abstract][Full Text] [Related]
15. Effect of nitric oxide donors on endogenous dopamine release from rat striatal slices. II: The role of voltage-dependent sodium channels, calcium channel activation, reverse transport mechanism, guanylate cyclase and endogenous glutamate. Büyükuysal RL Fundam Clin Pharmacol; 1997; 11(6):528-36. PubMed ID: 9444520 [TBL] [Abstract][Full Text] [Related]
16. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine. Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP J Neurochem; 1990 Jun; 54(6):1844-51. PubMed ID: 2338545 [TBL] [Abstract][Full Text] [Related]
17. Halothane potentiates the effect of methamphetamine and nomifensine on extracellular dopamine levels in rat striatum: a microdialysis study. Adachi YU; Watanabe K; Satoh T; Vizi ES Br J Anaesth; 2001 Jun; 86(6):837-45. PubMed ID: 11573593 [TBL] [Abstract][Full Text] [Related]
18. Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. De Deurwaerdère P; Spampinato U J Neurochem; 1999 Sep; 73(3):1033-42. PubMed ID: 10461892 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain. Fattaccini CM; Gozlan H; Hamon M Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793 [TBL] [Abstract][Full Text] [Related]
20. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Nomikos GG; Damsma G; Wenkstern D; Fibiger HC Neuropsychopharmacology; 1989 Dec; 2(4):273-9. PubMed ID: 2482026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]